Fig. 3From: Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal functionKidney function at baseline and follow-up. Estimated glomerular filtration rates (eGFR) before stereotactic ablative radiotherapy (pre SABR) and latest available follow-up (post SABR)Back to article page